Rite Aid Corporation's elevated risk of financial failure might be imperceptible if a credit and procurement managers put too much stock into whether or not the pharma retail mainstay continues to pay bills on time.
Major drug manufacturers Mallinckrodt plc and Endo International plc are financially distressed due to elevated debt and product-related risks. If your company is doing business with these manufacturers, you should evaluate your risk exposure and perform further research.
Popular drugstore retailer Rite Aid Corporation's heightened bankruptcy risk coincides with one-time competitor Walgreens swooping in and converting brick-and-mortar stores to their own brand and system.
Retail leader Fred's, Inc. tried to stave off Chapter 11 with new leadership while hundreds of their drugstores closed for good. A household name in much of the U.S., we look at what led to their rapid decline.
American healthcare services leader Owens & Minor, Inc. is trending towards a higher probability of bankruptcy. We advise continuous, thorough checkups of your portfolio when assessing public company financial risk.
Leveraging AI for accurate private company bankruptcy risk assessment, we were successful in predicting 70% of bankruptcies thus far in 2019 with the PAYCE® score.
CreditRiskMonitor currently estimates that financial losses stemming from U.S. public company bankruptcies alone will be in excess of $1.1 trillion, a greater figure than what was lost during the Great Recession.
The global economy appears to have deteriorated in a significant way during 2019 given the trends in negative yielding debt.
NantHealth, Inc. is experiencing some major distress. In this report, we diagnose their dangerous dealings in debt and what you can do as a creditor or a supplier to avoid risk.
When the FRISK® score becomes your go-to metric for financial risk analysis, incredibly accurate (read: good) adjustments follow.
It's unhealthy to think public company bankruptcy risk is a myth -- we show you why in this High Risk Report focusing on Quorum Health Corporation.
Two major U.S. pharmaceutical companies possess heightened bankruptcy risk largely due to lawsuits stemming from the opioid crisis. Our models are reflexive enough to give the most accurate forward-looking reads on financial risk when calamities strike.